期刊文献+

卵巢癌组织及细胞株中肿瘤特异性抗原MAGE、GAGE、BAGE基因表达的研究 被引量:2

Expression of tumor specific antigen MAGE,BAGE,GAGE in ovarian cancer tissues and cell lines
下载PDF
导出
摘要 目的:观察卵巢上皮性癌组织及细胞株中肿瘤特异性抗原MAGE、BAGE、GAGE基因的表达,以探讨基因表达与诊断、治疗及预后的关系,评价基因产物作为卵巢癌标志物以及卵巢癌免疫治疗靶位的可行性。方法:采用RT-PCR分析10例正常卵巢2、0例卵巢良性肿瘤、47例卵巢上皮性癌组织及3种卵巢癌细胞株SKOV3、A2780、COC1中MAGE-1、MAGE-3、GAGE-1/2及BAGE基因mRNA水平的表达。结果:正常卵巢组织中MAGE、GAGE、BAGE基因无表达,良性肿瘤中仅有MAGE-1基因表达,阳性率为15%(3/20)。卵巢癌组织MAGE-1、MAGE-3的表达率较高,分别为51.1%(25/47)、34%(16/47),GAGE-1/2及BAGE基因在卵巢癌组织中的表达率分别为25.5%(12/47)和14.9%(7/47)。卵巢癌转移灶仅有MAGE-1、BAGE基因表达,阳性表达率分别为28.6%(2/7)、14.3%(1/7)。浆液性囊腺癌MAGE-1、MAGE-3基因阳性表达率明显高于其它类型卵巢恶性肿瘤(P<0.05)。结论:肿瘤特异性抗原MAGE、GAGE、BAGE基因在卵巢癌中有较高表达,其表达与有无淋巴结转移无关,MAGE-1、MAGE-3基因的阳性表达与肿瘤分化程度及临床分期密切相关,伴有腹水的卵巢癌患者BAGE表达的阳性率较高。卵巢癌细胞株SKOV3、A2780、COC1的表达谱不尽相同,但至少有一种基因表达,其可作为卵巢癌免疫治疗的特异性靶点。 Objective: To explore the expression of MAGE, BAGE and GAGE genes in ovarian cancer tissues and cell lines. Methods: Expression levels of MAGE-1, MAGE-3, GAGE-1/2 and BAGE were determined by reverse transcription polymerase chain reaction(FF-PCR) in ovarian cancer cell lines SKOV3, A2780, COC1, and 10 cases of normal ovarian tissues, 20 cases of benign epithelial tumor, and 47 cases of malignant epithelial tumor. Results: Normal ovarian tissues did not express members of the above gene families. In benign tumor tissue specimens, only 3 cases expressed MAGE-1 (3/20). MAGE-1, MAGE-3, GAGE-1/2 and BAGE was expressed in 25(51.1%),16(34%), 12(25.5% ), 7(14.9%) cases of 47 ovarian cancer tissues. Conclusion: High expression of MAGE, BAGE and GAGE genes is produced in ovarian cancer tissues, which is related to the tumor grade, clinical stage, ascites, and the histological subtype, but is not related to age and lymph node metastasis. There was at least one of these genes expressed in ovarian cancer cell line SKOV3, A2780, and COC1. These tumor-specific antigens can be used as molecular markers for diagnosis and possible targets for immunotherapy.
出处 《山东大学学报(医学版)》 CAS 北大核心 2007年第8期762-766,共5页 Journal of Shandong University:Health Sciences
基金 山东省优秀中青年科研基金资助课题(2005BS03012)
关键词 卵巢肿瘤 肿瘤特异性抗原 基因 MAGE 基因 BAGE 基因 GAGE Ovarian neoplasms Tumor specific antigen MAGE gene BAGE gene GAGE gene
  • 相关文献

参考文献9

  • 1Van der Bruggen P,Traversari C,Chomze P,et al.A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma[J].Science,1991,254(5038):1643-1647.
  • 2Hofmann M,Ruschenburg I.mRNA detection of tumor-rejection genes BAGE,GAGE,and MAGE in peritoneal fluid from patients with ovarian carcinoma as a potential diagnostic tool[J].Cancer Cytopathology,2002,96(3):187-193.
  • 3Russo V,Dalerba P,Ricci A,et al.MAGE,BAGE and GAGE genes experiences in fresh epithelial ovarian carcinomas[J].Int J Cancer,1996,67(3):457-460.
  • 4Gillespie AM,Rodgers S,Wilson AP,et al.MAGE,BAGE and GAGE:tumor antigen expression in begin and malignant ovarian tissue[J].Br J Cancer,1998,78(6):816-821.
  • 5Figueiredo DL,Mamede RC,Proto-Siqueira R,et al.Expression of cancer testis antigens in head and neck squamous cell carcinomas[J].Head Neck,2006,10(2):132-137.
  • 6Ito S,Kawano Y,Katakura H,et al.Expression of MAGE-D4,a novel MAGE family antigen,is correlated with tumor-cell proliferation of non-small cell lung cancer[J].Lung Cancer,2006,51(1):79-88.
  • 7Chitale DA,Jungbluth AA,Marshall DS,et al.Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray[J].Mod Pathol,2005,18(1):119-126.
  • 8李芳,朱怀仕,贾平,高庆蕾,徐茜,刘德艳,王世宣,卢运萍,马丁.卵巢癌患者自体肿瘤细胞疫苗的临床应用[J].中华妇产科杂志,2004,39(1):51-52. 被引量:2
  • 9Ma Z,Khatlani TS,Ohno K,et al.Cloning and sequencing of canine MAGE cDNA[J].Tissue Antigens,2000,56(2):166-169.

共引文献1

同被引文献36

  • 1唐杰.胸腔积液274例病因分析[J].实用全科医学,2006,4(4):438-438. 被引量:5
  • 2赵飞兰,蓝玲,罗国容,谢小薰.肝癌细胞株中肿瘤特异性抗原GAGE基因mRNA的表达[J].华夏医学,2006,19(3):392-393. 被引量:3
  • 3范家珊.胸水C-反应蛋白在鉴别结核性及癌性胸腔积液中的价值[J].实用全科医学,2006,4(5):515-516. 被引量:3
  • 4吴喜梅,张师前,周晓亮,石琰.肿瘤特异性抗原MAGE、BAGE、GAGE在子宫内膜癌组织中表达的研究[J].山东大学学报(医学版),2006,44(10):1004-1007. 被引量:2
  • 5Parkin DM,Pisani P,Ferlay J.Estimates of the worldwide incidence of 25 major cancers in 1990.Int J Cancer 1999; 80:827-841.
  • 6Asha G,Vijayalakshmi D,Veerendra Kumar KV.Relationship between risk factors and dietary intake of oesophageal cancer patients.J Hum Ecol 2005; 17:39-42.
  • 7Freedman ND,Abnet CC,Leitzmann MF,Mouw T,Subar AF,Hollenbeck AR,Schatzkin A.A prospective study of tobacco,alcohol,and the risk of esophageal and gastric cancer subtypes.Am J Epidemiol 2007; 165:1424-1433.
  • 8Kashyap MK,Marimuthu A,Kishore CJ,Peri S,Keerthikumar S,Prasad TS,Mahmood R,Rao S,Ranganathan P,Sanjeeviah RC,Vijayakumar M,Kumar KV,Montgomery EA,Kumar RV,Pandey A.Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers.Cancer Biol Ther 2009; 8:36-46.
  • 9McCann J.Esophageal cancers:changing character,increasing incidence.J Natl Cancer Inst 1999; 91:497-498.
  • 10Wakatsuki M,Suzuki Y,Nakamoto S,Ohno T,Ishikawa H,Kiyohara H,Kiyozuka M,Shirai K,Nakayama Y,Nakano T.Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy.J Gastroenterol Hepatol 2007; 22:715-719.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部